Skip to main content
NewslettersWatchlist

Avita Medical Inc(RCEL-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low8.04
Day High8.39
Open:8.29
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Barchart
Technology Stocks Power the Broader Market Higher
Barchart
Stock Indexes Rise in Afternoon Trade
Barchart
Stocks Slightly Higher as US Mar PPI Climbs Less Than Expected
Barchart
Stock Index Futures are Higher after Wholesale Prices Increased Less Than Expected in March
Motley Fool
Why Shares of Avita Medical Are Down Monday
Motley Fool
Why Shares of Avita Medical Are Soaring Thursday
Globe Newswire
AVITA Medical to Announce Second Quarter 2022 Financial Results
Globe Newswire
AVITA Medical Reports First Quarter 2022 Financial Results
Globe Newswire
RECELLยฎ System to be Highlighted at Upcoming Music City SCALE Multidisciplinary Dermatology Meeting
Globe Newswire
AVITA Medical to Announce First Quarter 2022 Financial Results
Globe Newswire
RECELLยฎ System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation Annual Scientific Symposium
Globe Newswire
AVITA Medical Announces Modification of BARDA Contract to Advance Development of RECELLยฎ System in Soft Tissue Reconstruction
Globe Newswire
Avita Medical, Inc. Signs Agreement with Premier, Inc. to Supply the RECELLยฎ System to Hospitals and Health Systems Across the U.S.
Globe Newswire
AVITA Medical Reports Quarter Ending December 31, 2021, and Transition Periodย July 1, 2021, to December 31, 2021, Financial Results
Globe Newswire
The RECELLยฎ System Receives PMDA Approval in Japan and AVITA Medical will Commercialize in Partnership with COSMOTEC, an M3 Group Company
Globe Newswire
AVITA Medical to Present at the Cowen 42nd Annual Health Care Conference
Globe Newswire
AVITA Medical Announces FDA Approval of New RECELLยฎ System with Improved Ease of Use
Globe Newswire
AVITA Medical to Announce Transition Period July 1, 2021 to December 31, 2021 Financial Results
Globe Newswire
AVITA Medical to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Globe Newswire
RECELLยฎย System Data to be Presented at 44th Annual John A. Boswick Burn & Wound Care Symposium
Globe Newswire
AVITA Medical Announces Preliminary Unaudited Results for the Quarter ended December 31, 2021
Globe Newswire
AVITA Medical Completes Enrollment in Pivotal Trial Evaluating the RECELLยฎย System for Soft-Tissue Reconstruction
Globe Newswire
AVITA Medical Completes Enrollment in Pivotal Trial Evaluating the RECELLยฎ System for Repigmentation of Stable Vitiligo
Globe Newswire
AVITA Medical, Inc. Announces Adjournment of 2021 Annual Stockholder Meeting
Globe Newswire
AVITA Medical to Present at Upcoming Investor Conferences
Globe Newswire
AVITA Medical Reports First Fiscal Quarter 2022 Financial Results
Globe Newswire
Regional Burn Conferences Feature 12 RECELLยฎ System Data Presentations by Prominent Burn Surgeons
Globe Newswire
AVITA Medical to Announce Fiscal First Quarter 2022 Financial Results
Globe NewsWire
AVITA Medical to Present at the 2021 Cantor Virtual Global Healthcare Conference
Globe NewsWire
AVITA Medical to Participate at the Lake Street 2021 BIG5 Conference
Globe NewsWire
AVITA Medical Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Globe NewsWire
FDA Approves IDE Amendment to a Single-Arm Design for AVITA Medicalโ€™s Pivotal Study of the RECELLยฎ System for Vitiligo Treatment

Profile

AVITA Medical Inc. is a regenerative medicine company. It engages in developing and commercializing a technology platform which enables point-of-care autologous skin restoration for multiple unmet needs. AVITA Medical Inc., formerly known as AVITA Therapeutics Inc., is based in VALENCIA, Calif.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright ยฉ 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright ยฉ 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.